Parametric Portfolio Associates LLC raised its position in Smith & Nephew SNATS, Inc. (NYSE:SNN) by 6.5% during the second quarter, according to its most recent filing with the SEC. The firm owned 444,051 shares of the medical equipment provider’s stock after purchasing an additional 27,126 shares during the period. Parametric Portfolio Associates LLC owned 0.10% of Smith & Nephew SNATS worth $15,475,000 as of its most recent filing with the SEC.

Several other hedge funds and other institutional investors have also recently modified their holdings of the company. Bahl & Gaynor Inc. lifted its position in shares of Smith & Nephew SNATS by 0.3% in the 2nd quarter. Bahl & Gaynor Inc. now owns 21,440 shares of the medical equipment provider’s stock worth $645,000 after purchasing an additional 60 shares during the period. Curbstone Financial Management Corp lifted its position in shares of Smith & Nephew SNATS by 1.0% in the 2nd quarter. Curbstone Financial Management Corp now owns 15,600 shares of the medical equipment provider’s stock worth $544,000 after purchasing an additional 150 shares during the period. Wrapmanager Inc. lifted its position in shares of Smith & Nephew SNATS by 2.1% in the 2nd quarter. Wrapmanager Inc. now owns 10,178 shares of the medical equipment provider’s stock worth $355,000 after purchasing an additional 207 shares during the period. Wetherby Asset Management Inc. lifted its position in shares of Smith & Nephew SNATS by 2.6% in the 2nd quarter. Wetherby Asset Management Inc. now owns 16,415 shares of the medical equipment provider’s stock worth $572,000 after purchasing an additional 415 shares during the period. Finally, Bank of Montreal Can lifted its position in shares of Smith & Nephew SNATS by 2.4% in the 2nd quarter. Bank of Montreal Can now owns 23,873 shares of the medical equipment provider’s stock worth $831,000 after purchasing an additional 558 shares during the period. Hedge funds and other institutional investors own 6.36% of the company’s stock.

Smith & Nephew SNATS, Inc. (NYSE:SNN) opened at 36.61 on Friday. The firm has a market cap of $16.03 billion, a P/E ratio of 18.64 and a beta of 0.74. Smith & Nephew SNATS, Inc. has a 52-week low of $26.97 and a 52-week high of $37.22. The company’s 50 day moving average is $36.23 and its 200-day moving average is $34.54.

The firm also recently declared a semiannual dividend, which will be paid on Wednesday, November 1st. Investors of record on Friday, October 6th will be paid a $0.246 dividend. This represents a yield of 1.37%. The ex-dividend date is Thursday, October 5th.

A number of research analysts have recently issued reports on SNN shares. BidaskClub upgraded shares of Smith & Nephew SNATS from a “buy” rating to a “strong-buy” rating in a research report on Friday, June 23rd. Zacks Investment Research upgraded shares of Smith & Nephew SNATS from a “hold” rating to a “buy” rating and set a $41.00 price target on the stock in a research report on Wednesday, September 20th. Five research analysts have rated the stock with a hold rating and three have issued a buy rating to the company. Smith & Nephew SNATS currently has an average rating of “Hold” and an average price target of $41.00.

COPYRIGHT VIOLATION NOTICE: This piece was first reported by Watch List News and is the sole property of of Watch List News. If you are viewing this piece on another site, it was illegally stolen and reposted in violation of U.S. & international trademark & copyright laws. The legal version of this piece can be viewed at https://www.watchlistnews.com/smith-nephew-snats-inc-snn-stake-lifted-by-parametric-portfolio-associates-llc/1614916.html.

About Smith & Nephew SNATS

Smith & Nephew plc is a medical technology company. The Company is engaged in developing, manufacturing, marketing and selling medical devices and services. Its products and services include Sports Medicine Joint Repair, Arthroscopic Enabling Technologies (AET), Trauma & Extremities, Other Surgical Businesses, Knee Implants, Hip Implants, Advanced Wound Care, Advanced Wound Bioactives and Advanced Wound Devices.

Institutional Ownership by Quarter for Smith & Nephew SNATS (NYSE:SNN)

Receive News & Ratings for Smith & Nephew SNATS Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Smith & Nephew SNATS Inc. and related companies with Analyst Ratings Network's FREE daily email newsletter.